NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Merck


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Compugen Announces Discovery of Genetic Biomarker for Predisposition to Type 2 Diabetes
2009 NOV 23 ... current collaborations include Bayer Schering Pharma, Biosite, Medarex, Inc., Merck & Co., Inc., Merck Serono, Ortho-Clinical Diagnostics ...
Subject: Compugen Ltd.
Price: $3.00
*
Faith-Based Investors Press Dozens of Top Companies to Say If U.S. Chamber of Commerce Speaks for Them in Opposing Health Care Reform
2009 NOV 23 ... faith-based institutional investors are pressuring 36 major companies -- including Merck, Wal-Mart, McDonald's, AT&T, IBM and General Electric -- to state publicly if the U.S. ...
Subject: Interfaith Center on Corporate Responsibility (ICCR), New York City
Price: $3.00
*
Former Pfizer Global R&D President John LaMattina Joins PureTech Ventures as Senior Partner; PureTech Announces Partner Promotions
2009 NOV 23 ... Dr. Bennett Shapiro, (Chairman, former EVP Worldwide Basic and External Research, Merck); Dr. John Zabriskie (former CEO Pharmacia & Upjohn); Dr. Ronald Cape (Founder, Cetus); ...
Subject: Diabetes
Price: $3.00
*
Fred Hassan Joins Bausch & Lomb Board of Directors
2009 NOV 23 ... was chairman and CEO of Schering-Plough Corporation from 2003 until its acquisition by Merck & Co., Inc. on November 3. Before joining Schering-Plough, he served as CEO (from 2000 ...
Subject: Pharmaceuticals
Price: $3.00
*
GTx, Inc. Reports Third Quarter 2009 Corporate Results
2009 NOV 23 ... GTx plans to announce results of the clinical trial in 2010. The GTx and Merck & Co. Inc. collaboration for the discovery, development and commercialization of ...
Subject: GTx, Inc.
Price: $3.00
*
Heartbeat Digital to Speak at FDA Hearing
2009 NOV 23 ... Life Line Screening, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Merck, Millennium, Otsuka, sanofi-aventis, and UCB. Heartbeat Digital publishes a ...
Subject: Heartbeat Digital
Price: $3.00
*
ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders
2009 NOV 23 ... GlaxoSmithKline and its predecessor, SmithKline Beecham, at Abbott Laboratories and at Merck & Co. He is also a director of ViroPharma Incorporated and Vanda Pharmaceuticals. ...
Subject: ImmunoGen, Inc.
Price: $3.00
*
New findings in life sciences described from Merck & Company, Inc.
2009 NOV 23 ... attenuated MK-801-induced psychomotor activity," wrote J.M. Uslaner and colleagues, Merck & Company, Inc. The researchers concluded: "Our results suggest that a ...
Subject: Life Sciences
View Free
Daily News
Article
New Survey Reveals Unmet Needs In Asthma Care In the U.s.
2009 NOV 23 ... Stoloff, M.D. The survey was sponsored by Schering Corporation; Schering-Plough and Merck & Co. Inc. merged on November 3, 2009. About...
Subject: Asthma
Price: $3.00
*
Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
2009 NOV 23 ... activities for Stimuvax and the transfer of our Edmonton, Alberta facility to Merck KGaA. General and administrative expenses decreased to $1.4 million in the three months ...
Subject: Oncothyreon Inc.
Price: $3.00
*
OPKO Health Completes Acquisition of NK-1 Compounds from Schering Corporation
2009 NOV 23 ... of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co., Inc. ("Schering"). Rolapitant, a neurokinin-1 (NK-1) receptor ...
Subject: OPKO Health, Inc.
Price: $3.00
*
Per Capita Expenditure on the Netherlands Pharmaceutical Products Is Considerably Lower Than Nearby Belgium, France or Germany at US$573 In 2009
2009 NOV 23 ... Local Manufacturers Organon DSM BV Merck Generics Group Multipharma B.V Pharmachemie B.V ...
Subject: Research and Markets
Price: $3.00
*
Photos: 'Project Runway' Designer Launches New Video in Online Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma
2009 NOV 23 ... to help the HIV and AIDS community. The Living Positive By Design campaign, supported by Merck & Co., Inc., and videos aim to confront HIV stigma and motivate HIV-positive people to ...
Subject: HIV/AIDS
Price: $3.00
*
PPD Completes Acquisition of Excel PharmaStudies
2009 NOV 24 ... testing capabilities when it acquired a vaccine testing lab in Wayne, Penn., from Merck & Co., Inc.PPD opened its Beijing office in 2003, where it provides a broad ...
Subject: PPD, Inc.
Price: $3.00
*
Pyro Pharmaceuticals, Inc. Announces the Appointment of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board
2009 NOV 23 ... scientific advisory boards of major pharmaceutical and biotechnology companies including Merck, Glaxo, Vertex, Chiron, Abbott, Bristol Myers Squibb, Rhone-Poulenc Rorer, and Hoechst ...
Subject: Fero Industries, Inc.
Price: $3.00
*
Research from Merck & Company, Inc. provide new insights into managed care
2009 NOV 23 ... of hospital stays compared with other plan types," wrote P.B. Landsman and colleagues, Merck & Company, Inc. The researchers concluded: "As previously shown among ...
Subject: Managed Care
View Free
Daily News
Article
Research from Merck & Company, Inc. yields new data on clinical trial research
2009 NOV 23 ... of BRAEs in patients receiving montelukast or placebo in a retrospective analysis of Merck clinical trial data." "An adverse experience database was constructed to ...
Subject: Clinical Trial Research
View Free
Daily News
Article
Study data from A. Pocai and co-authors update knowledge of obesity and diabetes
2009 NOV 23 ... 2009;58(10):2258-2266). For additional information, contact A. Pocai, Merck Research Laboratories, Rahway, NJ, USA. The publisher's contact ...
Subject: Obesity and Diabetes
Price: $3.00
*
Survey Reveals Too Many People With Asthma May Accept a High Burden of Disease
2009 NOV 25 ... Keywords: Allergies, Allergy Medicine, Asthma, Schering CORP.; SCHERING-PLOUGH & Merck & CO. INC. Merged On 11/3/09. This article was prepared by Immunotherapy ...
Subject: Asthma
Price: $3.00
*
Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
2009 NOV 23 ... after the introduction of the HPV vaccine, Gardasil®, which was developed by Merck & Co. (NYSE: MRK). The TrovaGene HPV DNA test involves isolation of DNA ...
Subject: Xenomics, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login